Hims & Hers Health's Telehealth Stock Climbs 0.62% but Slides to 72nd in U.S. Volume After 45% Drop

Generated by AI AgentAinvest Volume Radar
Friday, Sep 5, 2025 9:13 pm ET1min read
ETC--
Aime RobotAime Summary

- Hims & Hers Health (HIMS) rose 0.62% on Sept 5, 2025, but daily trading volume fell 45.49% to $1.15B, ranking 72nd in U.S. volume.

- The telehealth platform connects patients globally to licensed providers, offering prescriptions, OTC products, and wellness services via digital care.

- Its business model focuses on recurring prescriptions and partnerships, spanning sexual health, skincare, and hair care products like minoxidil.

- The volume decline highlights market skepticism about its growth strategy despite expanding product offerings and international reach.

On September 5, 2025, , , . stocks by volume. The company’s telehealth platform connects patients to licensed healthcare providers across the U.S., U.K., and international markets, offering prescription medications, over-the-counter products, and wellness services through its digital ecosystem. Its product range spans sexual health, skincare, hair care, and general wellness, including curated items like melatonin, minoxidil, and medical devices. The business model emphasizes recurring prescriptions and ongoing care, supported by wholesale partnerships and post-consultation services.

To run this back-test effectively I need a little more detail about how you’d like the daily “top-500-by-volume” portfolio to be formed and measured: 1. UniverseUPC-- • Which market(s) should we scan each day—e.g., , or another exchange/universe? 2. , , etcETC--.? 3. , or weight by something else (e.g., dollar-volume)? 4. , ? 5. ? .

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.